India’s Eris Lifesciences launches generic semaglutide at $13.8 per month
- ByInvesting.com-
Investing.com -- India’s Eris Lifesciences launched one of the most affordable versions of generic semaglutide on Friday, with the...
Last | High | Low | |||||
|---|---|---|---|---|---|---|---|
| 1,927.10 | 1,974.40 | 1,919.90 | -9.70 | -0.50% | 1.18M | ||
| 7,364.50 | 7,447.50 | 7,202.50 | +112.50 | +1.55% | 696.46K | ||
| 2,195.40 | 2,224.50 | 2,185.00 | +9.40 | +0.43% | 875.92K | ||
| 1,203.90 | 1,231.80 | 1,199.70 | -3.10 | -0.26% | 7.52M | ||
| 9,051.00 | 9,110.00 | 8,931.50 | +182.50 | +2.06% | 356.41K | ||
| 830.55 | 841.95 | 819.25 | -1.65 | -0.20% | 14.88M | ||
| 1,710.30 | 1,734.00 | 1,702.80 | -4.60 | -0.27% | 2.63M | ||
| 1,846.10 | 1,860.90 | 1,834.00 | +19.10 | +1.05% | 7.69M | ||
| 426.10 | 438.95 | 424.70 | -4.70 | -1.09% | 17.6M | ||
| 1,256.40 | 1,264.00 | 1,248.00 | +17.20 | +1.39% | 1.15M | ||
| 468.15 | 472.40 | 456.20 | +13.95 | +3.07% | 23.88M | ||
| 1,298.90 | 1,307.50 | 1,288.20 | +24.40 | +1.91% | 3.36M | ||
| 6,909.00 | 6,928.00 | 6,802.50 | +116.00 | +1.71% | 575.12K | ||
| 2,616.30 | 2,662.70 | 2,608.30 | +8.40 | +0.32% | 1.51M | ||
| 1,333.70 | 1,352.50 | 1,328.90 | +21.90 | +1.67% | 5.05M | ||
| 780.45 | 793.75 | 778.20 | -17.75 | -2.22% | 103.13M | ||
| 5,275.50 | 5,367.50 | 5,216.00 | +103.00 | +1.99% | 1.04M | ||
| 2,082.70 | 2,099.80 | 2,069.00 | +5.40 | +0.26% | 2.43M | ||
| 874.25 | 907.50 | 870.00 | -22.80 | -2.54% | 10.06M | ||
| 1,245.40 | 1,274.00 | 1,241.70 | -4.70 | -0.38% | 16.42M | ||
| 818.60 | 837.00 | 813.10 | +2.30 | +0.28% | 7.87M | ||
| 1,255.90 | 1,264.80 | 1,229.20 | +35.10 | +2.88% | 27.3M | ||
| 299.95 | 308.75 | 298.15 | +1.95 | +0.65% | 58.68M | ||
| 1,169.60 | 1,186.50 | 1,138.00 | +38.70 | +3.42% | 3.58M | ||
| 366.75 | 372.60 | 365.40 | -1.40 | -0.38% | 17.08M | ||
| 3,434.80 | 3,524.00 | 3,410.00 | +0.30 | +0.01% | 4.74M | ||
| 3,066.10 | 3,106.60 | 3,043.20 | +20.70 | +0.68% | 4.47M | ||
| 12,601.00 | 12,756.00 | 12,556.00 | +2.00 | +0.02% | 725.48K | ||
| 1,365.40 | 1,393.50 | 1,358.00 | +9.40 | +0.69% | 4.21M | ||
| 380.95 | 383.30 | 375.50 | +6.90 | +1.84% | 20.93M | ||
| 265.40 | 273.05 | 264.00 | -3.70 | -1.37% | 19.44M | ||
| 297.60 | 305.00 | 296.60 | +0.90 | +0.30% | 28.39M | ||
| 1,414.40 | 1,430.00 | 1,396.10 | +29.60 | +2.14% | 22.99M | ||
| 1,058.00 | 1,085.00 | 1,054.00 | +9.10 | +0.87% | 17.75M | ||
| 938.60 | 966.90 | 922.30 | -11.20 | -1.18% | 28.55M | ||
| 1,777.10 | 1,781.30 | 1,754.30 | +32.70 | +1.87% | 3.59M | ||
| 2,390.60 | 2,407.80 | 2,364.20 | +34.60 | +1.47% | 4.21M | ||
| 1,050.20 | 1,056.00 | 1,043.50 | +5.60 | +0.54% | 2.1M | ||
| 314.10 | 316.90 | 310.80 | +4.80 | +1.55% | 13.91M | ||
| 196.77 | 199.44 | 193.34 | +6.26 | +3.29% | 46.88M | ||
| 1,384.80 | 1,391.00 | 1,355.60 | +44.20 | +3.30% | 3.4M | ||
| 4,106.60 | 4,149.90 | 4,040.90 | +68.70 | +1.70% | 1.02M | ||
| 3,559.60 | 3,598.00 | 3,506.40 | +77.70 | +2.23% | 837.22K | ||
| 10,934.00 | 10,974.00 | 10,853.00 | +120.00 | +1.11% | 365.91K | ||
| 190.90 | 192.30 | 188.41 | +2.49 | +1.32% | 24.4M | ||
| 1,193.60 | 1,204.00 | 1,177.60 | +7.30 | +0.62% | 1.4M | ||
| 1,896.90 | 1,919.90 | 1,890.00 | -6.20 | -0.33% | 1.78M | ||
| 623.65 | 635.50 | 622.05 | -9.85 | -1.55% | 3.01M | ||
| 232.29 | 236.70 | 230.10 | +3.55 | +1.55% | 55.78M | ||
| 239.30 | 244.25 | 238.60 | -0.15 | -0.06% | 15.02M |
Investing.com -- India’s Eris Lifesciences launched one of the most affordable versions of generic semaglutide on Friday, with the...
Synopsis: With the stock delivering a 3-year compounded return of 50 percent, it surged after converting preference shares into...
Synopsis: Mahindra EPC Irrigation and two other stocks are in focus after securing significant contracts in micro-irrigation,...
In today’s market analysis, the focus is on the State Bank of India and the key trading levels that could shape its movement in...
TAKE Solutions: From Legacy Services to AI-Driven Preventive Healthcare – A 2026 Transformation TAKE Solutions Limited (NSE: TAKE,...
Advanced Micro Devices (NASDAQ:AMD) is trading at $201.09 Thursday, down 0.48% with a day range of $197.39 to $203.79, market cap...
No Earning Reports have been scheduled